Searle & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $4.88M | Sell |
78,200
-1,500
| -2% | -$94.8K | 1.17% | 23 |
|
|
2026
Q2 | $4.59M | Sell |
79,700
-111
| -0.1% | -$6.37K | 1.03% | 27 |
|
|
2026
Q1 | $4.84M | Hold |
79,811
| – | – | 1.22% | 24 |
|
|
2025
Q4 | $4.31M | Buy |
79,811
+1,350
| +2% | +$64.9K | 1.11% | 26 |
|
|
2025
Q3 | $3.54M | Sell |
78,461
-5,899
| -7% | -$275K | 0.94% | 32 |
|
|
2025
Q2 | $3.91M | Sell |
84,360
-150
| -0.2% | -$7.36K | 1.1% | 30 |
|
|
2025
Q1 | $5.15M | Hold |
84,510
| – | – | 1.47% | 19 |
|
|
2024
Q4 | $4.78M | Hold |
84,510
| – | – | 1.38% | 20 |
|
|
2024
Q3 | $4.37M | Sell |
84,510
-9,836
| -10% | -$461K | 1.09% | 23 |
|
|
2024
Q2 | $3.92M | Buy |
94,346
+1,765
| +2% | +$79K | 0.92% | 25 |
|
|
2024
Q1 | $5.02M | Sell |
92,581
-11,500
| -11% | -$586K | 1.28% | 18 |
|
|
2023
Q4 | $5.34M | Buy |
104,081
+11,048
| +12% | +$580K | 1.46% | 18 |
|
|
2023
Q3 | $5.4M | Sell |
93,033
-111
| -0.1% | -$6.8K | 1.84% | 14 |
|
|
2023
Q2 | $5.79M | Sell |
93,144
-112
| -0.1% | -$7.51K | 1.79% | 13 |
|
|
2023
Q1 | $6.23M | Hold |
93,256
| – | – | 2.04% | 9 |
|
|
2022
Q4 | $6.71M | Hold |
93,256
| – | – | 2.29% | 7 |
|
|
2022
Q3 | $6.63M | Hold |
93,256
| – | – | 2.55% | 6 |
|
|
2022
Q2 | $7.18M | Hold |
93,256
| – | – | 2.83% | 5 |
|
|
2022
Q1 | $6.81M | Buy |
93,256
+100
| +0.1% | +$6.71K | 2.51% | 5 |
|
|
2021
Q4 | $5.81M | Sell |
93,156
-400
| -0.4% | -$23.5K | 2.11% | 7 |
|
|
2021
Q3 | $5.54M | Hold |
93,556
| – | – | 2.27% | 7 |
|
|
2021
Q2 | $6.25M | Buy |
93,556
+389
| +0.4% | +$25.4K | 2.56% | 4 |
|
|
2021
Q1 | $5.88M | Hold |
93,167
| – | – | 2.62% | 5 |
|
|
2020
Q4 | $5.78M | Buy |
93,167
+1,600
| +2% | +$98.4K | 2.78% | 5 |
|
|
2020
Q3 | $5.52M | Hold |
91,567
| – | – | 3.01% | 4 |
|
|
2020
Q2 | $5.38M | Hold |
91,567
| – | – | 3.12% | 3 |
|
|
2020
Q1 | $5.1M | Hold |
91,567
| – | – | 3.62% | 2 |
|
|
2019
Q4 | $5.88M | Hold |
91,567
| – | – | 3.24% | 2 |
|
|
2019
Q3 | $4.64M | Buy |
91,567
+1,834
| +2% | +$86.2K | 2.74% | 5 |
|
|
2019
Q2 | $4.07M | Sell |
89,733
-317
| -0.4% | -$14.8K | 2.47% | 7 |
|
|
2019
Q1 | $4.3M | Sell |
90,050
-548
| -0.6% | -$27.3K | 2.68% | 4 |
|
|
2018
Q4 | $4.71M | Hold |
90,598
| – | – | 3.31% | 4 |
|
|
2018
Q3 | $5.62M | Sell |
90,598
-90
| -0.1% | -$5.34K | 3.3% | 3 |
|
|
2018
Q2 | $5.02M | Buy |
90,688
+1,000
| +1% | +$54K | 3.18% | 3 |
|
|
2018
Q1 | $5.67M | Buy |
89,688
+500
| +0.6% | +$32.2K | 3.69% | 3 |
|
|
2017
Q4 | $5.46M | Sell |
89,188
-112
| -0.1% | -$7K | 3.43% | 4 |
|
|
2017
Q3 | $5.69M | Buy |
89,300
+200
| +0.2% | +$11.7K | 3.76% | 2 |
|
|
2017
Q2 | $4.96M | Sell |
89,100
-1,400
| -2% | -$76.2K | 3.41% | 4 |
|
|
2017
Q1 | $4.92M | Buy |
90,500
+100
| +0.1% | +$5.48K | 3.45% | 4 |
|
|
2016
Q4 | $5.28M | Buy |
90,400
+24,200
| +37% | +$1.32M | 4.38% | 2 |
|
|
2016
Q3 | $3.66M | Buy |
+66,200
| New | +$4.25M | 3.18% | 3 |
|
|
2016
Q2 | – | Sell |
-64,616
| Closed | -$4.19M | – | 37 |
|
|
2016
Q1 | $4.19M | Buy |
64,616
+300
| +0.5% | +$18.9K | 3.86% | 2 |
|
|
2015
Q4 | $4.31M | Hold |
64,316
| – | – | 4.14% | 2 |
|
|
2015
Q3 | $3.81M | Buy |
64,316
+200
| +0.3% | +$12.7K | 3.91% | 2 |
|
|
2015
Q2 | $4.27M | Hold |
64,116
| – | – | 3.56% | 2 |
|
|
2015
Q1 | $4.14M | Buy |
64,116
+1,166
| +2% | +$73K | 3.56% | 2 |
|
|
2014
Q4 | $3.72M | Buy |
+62,950
| New | +$3.55M | 3.14% | 4 |
|
Other funds holding BMY
Searle & Co's BMY Position: Q3 2026 in Review
Searle & Co reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q3 2026, selling an estimated $94.8K and leaving 78,200 shares worth $4.88M. The position accounts for 1.17% of the portfolio, ranked #23.
Searle & Co first reported a position in BMY in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.18M in Q2 2022. 1,361 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Searle & Co held 78,200 shares of Bristol-Myers Squibb worth $4.88M as of Q3 2026.
- Searle & Co sold 1,500 Bristol-Myers Squibb shares in Q3 2026, an estimated $94.8K.
- Bristol-Myers Squibb made up 1.17% of Searle & Co's portfolio in Q3 2026, its #23 holding.
- Searle & Co first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 47 quarters since.
- Searle & Co's Bristol-Myers Squibb position peaked at $7.18M in Q2 2022.
- 1,361 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Searle & Co's 13F filing for Q3 2026, filed 4 Nov 2026.